Symbol="CABA"
AssetType="Common Stock"
Name="Cabaletta Bio Inc"
Description="Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of T-cell therapies designed for patients with B-cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania."
CIK="1759138"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="569212000"
EBITDA="-59470000"
PERatio="None"
PEGRatio="None"
BookValue="4.376"
DividendPerShare="0"
DividendYield="0"
EPS="-1.71"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.266"
ReturnOnEquityTTM="-0.426"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.71"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="19.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.311"
EVToRevenue="-"
EVToEBITDA="-2.221"
Beta="2.554"
num_52WeekHigh="15.39"
num_52WeekLow="0.59"
num_50DayMovingAverage="12.87"
num_200DayMovingAverage="9.91"
SharesOutstanding="39805000"
DividendDate="None"
ExDividendDate="None"
symbol="CABA"
open="14.30"
high="14.56"
low="13.68"
price="14.16"
volume="789129.00"
latest_trading_day="2023-08-31"
previous_close="14.30"
change="-0.14"
change_percent="-0.9790%"
aroon_positive_momentum_days="84"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="84"
Volume_recent_avg="436166"
Change_recent_avg="0.04"
Delta_recent_avg="0.94"
Variance_recent_avg="0.47"
Change_ratio_recent_avg="0.28"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="84"
Aroon_momentum_negative="16"
image_negative_thumbnail_id_1="1141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0174.jpeg"
image_negative_thumbnail_id_2="111"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="600"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0108.jpeg"
image_positive_thumbnail_id_2="986"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0148.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
